Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor Activity
NCT01533779 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2012-02-15
Summary
Examine neutrophil extracellular traps (NETs) formation, in relation to other neutrophil functions like chemotaxis, superoxide production, hydrogen peroxide production, and the presence of myeloperoxidase, in pediatric patients undergoing chemotherpy for solid and hematological malignancies. This data could shed new light on the mechanism responsible for the increased susceptibility to infection among these patients and aid in improving their prophylactic antimicrobial treatment.
NETs formation against tumor cell lines and their ability to kill tumor cells will also be examined. The finding of NETs activity against tumor cells could have a major contribution to the investigators understanding of the function of the immune system against cancer.
Conditions
- Pediatric Solid Malignancies
- Pediatric Hematological Malignancies
Sponsors & Collaborators
-
Max Planck Institute for Infection Biology
collaborator OTHER -
Meir Medical Center
collaborator OTHER -
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Principal Investigators
-
Sivan Achituv, MD · The department of pediatric hemato-oncology, Dana Childrens' Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
Eligibility
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2015-02-28
- Completion
- 2015-02-28
Countries
- Israel
Study Locations
More Related Trials
-
A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy
NCT04478292 ·Status: RECRUITING ·Phase: PHASE3
-
Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer
NCT01445379 ·Status: COMPLETED ·Phase: PHASE1
-
Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children
NCT00552825 ·Status: COMPLETED
-
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
NCT05634369 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Role of Children in Transmission of COVID-19 to Immunocompromised Patients
NCT04407546 ·Status: TERMINATED
-
Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies
NCT01683149 ·Status: COMPLETED ·Phase: PHASE1
-
Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors
NCT00148993 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]
NCT03686566 ·Status: COMPLETED
-
Emapalumab Efficacy in Children With Primary Hemophagocytic Lymphohistiocytosis
NCT06587191 ·Status: ACTIVE_NOT_RECRUITING
-
Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors
NCT00607984 ·Status: UNKNOWN ·Phase: NA
-
Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors
NCT03611595 ·Status: RECRUITING ·Phase: PHASE1
-
Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
NCT04659733 ·Status: UNKNOWN ·Phase: PHASE1
-
Intra-arterial Chemotherapy for Children With Retinoblastoma
NCT00906113 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
NCT02933333 ·Status: UNKNOWN ·Phase: PHASE4
-
A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas
NCT00001566 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 in Pediatric Oncology and Hematology Centers in France
NCT04433871 ·Status: UNKNOWN
-
Oxaliplatin for Children With Solid Tumors
NCT01558453 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia
NCT00520325 ·Status: WITHDRAWN ·Phase: PHASE1
-
Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia
NCT01688752 ·Status: WITHDRAWN
-
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
NCT06941272 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia
NCT04037189 ·Status: UNKNOWN
-
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients
NCT02963389 ·Status: COMPLETED ·Phase: PHASE1
-
Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma
NCT01944982 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety of Expanded Haploidentical Natural Killer Cells for Leukemia
NCT04327037 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia
NCT01184274 ·Status: COMPLETED ·Phase: PHASE1